King Wealth Management Group - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 69 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.52 and the average weighting 0.0%.

Quarter-by-quarter ownership
King Wealth Management Group ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$20
+300.0%
16,0000.0%0.00%
+300.0%
Q2 2023$5
-28.6%
16,0000.0%0.00%
-50.0%
Q1 2023$7
-12.5%
16,0000.0%0.00%0.0%
Q4 2022$8
-99.9%
16,0000.0%0.00%
-33.3%
Q3 2022$12,000
-33.3%
16,0000.0%0.00%
-25.0%
Q2 2022$18,000
-45.5%
16,0000.0%0.00%
-33.3%
Q1 2022$33,000
-61.2%
16,0000.0%0.01%
-64.7%
Q2 2021$85,000
+14.9%
16,0000.0%0.02%0.0%
Q1 2021$74,000
+39.6%
16,0000.0%0.02%
+41.7%
Q4 2020$53,00016,0000.01%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
AdvisorShares Investments LLC 610,045$2,014,0000.47%
ETF MANAGERS GROUP, LLC 1,814,328$5,987,0000.13%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 72,169$238,0000.06%
Bernardo Wealth Planning LLC 27,219$89,0000.03%
Affinity Asset Advisors, LLC 13,285$44,0000.02%
ALGERT GLOBAL LLC 20,778$69,0000.02%
ZEKE CAPITAL ADVISORS, LLC 49,700$164,0000.01%
Founders Capital Management 2,000$18,0000.01%
King Wealth Management Group 16,000$53,0000.01%
Penserra Capital Management LLC 129,252$425,0000.01%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders